Seasonal Influenza Vaccine Market in Asia-Pacific to 2018

presentation player overlay
About This Presentation
Transcript and Presenter's Notes

Title: Seasonal Influenza Vaccine Market in Asia-Pacific to 2018


1
Category Pharmaceuticals Healthcare
  • Seasonal Influenza Vaccine Market in Asia-Pacific
    to 2018 - Positive Impact of Government Support
    Offset by Limited Production Capacity, High
    Investment and Strict Regulations as Barriers to
    New Entrants

2
Synopsis
  • GBI Research, the leading business
    intelligence provider has released its latest
    research "Seasonal Influenza Vaccine Market in
    Asia-Pacific to 2018 - Positive Impact of
    Government Support Offset by Limited Production
    Capacity, High Investment and Strict Regulations
    as Barriers to New Entrants" which essentially
    provides insights into the seasonal influenza
    vaccine sales forecasts for the Asia-Pacific
    Region until 2018. The report also delves deep
    into vaccination patterns for seasonal influenza
    in the Asia-Pacific Region.
  • Browse Full Report http//www.aarkstore.com/ph
    armaceuticals-healthcare/109510/seasonal-influenza
    -vaccine-market-in-asia-pacific-to-2018-positive-i
    mpact-of-government-support-offset

3
Summary
  • Treatment of seasonal influenza is dominated
    by two categories of treatment options, vaccines
    and antiviral therapies. In the recent years it
    was observed that demand for seasonal influenza
    vaccines have increased due to changed perception
    of patient population. The patient population is
    of the opinion that preventive healthcare is
    better compared to curative healthcare this led
    to increased demand of vaccines in Asia-Pacific
    region. Asia-Pacific (APAC) region is an
    attractive market for seasonal influenza vaccine
    manufacturers. Major drivers in the market is
    increasing awareness, increasing vaccination
    coverage in the APAC countries and rising
    government support for immunization against
    seasonal influenza. Major restraints of the
    market are variable demand and limited production
    capacity. Traditional egg based manufacturing of
    seasonal influenza vaccines is being replaced
    with cell culture vaccines. Cell culture based
    production of vaccines is expected to reduce the
    problems associated with the production and use
    of seasonal influenza vaccines which will further
    increase the vaccination coverage in the APAC
    region.

4
Table of contents
  • 1.1. List of Tables1.2. List of Figures2.
    Introduction3. Seasonal Influenza Vaccine
    Market in Asia-Pacific - Market Overview3.1.
    Market Characterization and Forecasts3.2.
    Revenue by Geographical Segmentation4. Seasonal
    Influenza Vaccine Market in Asia-Pacific -
    Australia

5
Related Reports
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/111065/circadian-technologies-limited-product-pi
    peline-review-2015
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/111064/nabriva-therapeutics-ag-product-pipeline-
    review-2015
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/111063/acucela-inc-product-pipeline-review-2015
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/111062/acumen-pharmaceuticals-inc-product-pipeli
    ne-review-2015
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/111061/acacia-pharma-ltd-product-pipeline-review
    -2015

6
Seasonal Influenza Vaccine Market in
Asia-Pacific to 2018 - Positive Impact of
Government Support Offset by Limited Production
Capacity, High Investment and Strict Regulations
as Barriers to New Entrants
  • Published
    April 2013 137 Pages
  • GBI Research, the leading business
    intelligence provider has released its latest
    research "Seasonal Influenza Vaccine Market in
    Asia-Pacific to 2018 - Positive Impact of
    Government Support Offset by Limited Production
    Capacity, High Investment and Strict Regulations
    as Barriers to New Entrants" which essentially
    provides insights into the seasonal influenza
    vaccine sales forecasts for the Asia-Pacific
    Region until 2018.
  • Price

Format Price
PDF 3500
Site Licence 7000
Enterprise wide Licence 10500
7
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756
4953
You Can Visit http//www.aarkstore.com OR Mail
us at contact_at_aarkstore.com Blog
http//www.aarkstore.com/blog/ Conference
http//conference.aarkstore.com/ News
http//www.aarkstore.com/news
Write a Comment
User Comments (0)
About PowerShow.com